[ad_1]
Newark, Dell., October 25, 2022 /PRNewswire/ — The National Institute for Biopharmaceutical Manufacturing Innovation (NIIMBL) has launched NIIMBL bioLOGIC, a pilot program designed to increase career awareness and interest in the biopharmaceutical manufacturing industry. increase. NIIMBL partnered with the North Carolina Center for Biotechnology to select Southern Energy and Sustainability High School to pilot his five-week program that not only allows students to learn and innovate, but also visualize a career in the industry.
NIIMBL Workforce Development Director, John Balchunas “Bridging the perception gap and finding new opportunities to spark interest in a career in biopharmaceutical manufacturing early in the school year has been a path that has been very successful across the industry, and we are no exception. “We want students in all communities to understand that they are in a fast-growing, highly profitable industry that is vital to the health of people around the world,” added Balchunas. .
Southern High School of Energy and Sustainability Durham The region has seen strong growth in recent years and was selected for the pilot because of its 95% minority enrollment rate at the institution. By implementing this program at the Southern High School of Energy and Sustainability, black and Latino high school students will gain access to the biopharmaceutical manufacturing industry within their communities. “It is of utmost importance that students in this community know and understand what a career in this industry is and what qualifications are required to enter this field. It’s equally important to see people who look like you.” says Jaquera HillHealth Sciences Instructor at Southern High School.
NIIMBL bioLOGIC Program Coordinator Logan Modlin “Last year alone, companies such as Lilly, Merck and AveXis announced plans to create more than 1,500 biopharmaceutical manufacturing jobs. DurhamAs career prospects in manufacturing continue to grow in the region, it is imperative to ensure that local students are aware of the opportunities and ready to be part of this great community. ”
NIIMBL bioLOGIC was created in partnership with NextFlex. $5 million Funding from the Office of Naval Research (ONR). The purpose of this grant is to develop new educational programs modeled after NextFlex’ award-winning project-based learning FlexFactor® program.Following a successful pilot launch and expansion north carolinaNIIMBL looks forward to expanding the program to other regional ecosystems across the country.
The above work is sponsored by the Department of the Navy, Office of Naval Research under ONR award number N00014-20-1-2250. Any opinions, findings, conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the Office of Naval Research.
For more information on the NIIMBL bioLOGIC program, please visit NIIMBL.org.
About NIIMBL
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate innovation in biopharmaceuticals, support the development of standards that enable more efficient and faster manufacturing capabilities, and lead the world. to educate and train a biopharmaceutical manufacturing workforce that , fundamentally improve US competitiveness in this industry. NIIMBL is part of Manufacturing USA®, a diverse network of federally sponsored manufacturing innovation agencies and is funded through a cooperative agreement with the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST). It has received significant additional support from its members.
News media contact:
Maria X. Chacon
Director of Marketing and Communications
302-831-2337
[email protected]
Source National Biopharmaceutical Manufacturing Innovation Institute (NIIMBL)
[ad_2]
Source link
